You just read:

Fabre-Kramer Looks Forward to FDA's Decision on Gepirone ER for the Treatment of Major Depressive Disorder

News provided by

Fabre-Kramer Pharmaceuticals, Inc.

Dec 02, 2015, 01:40 ET